Palmitoylethanolamide (PEA) and Glaucoma – A Short Review

PEA is an endocannabinoid. Our bodies normally produce endocannabinoids, for example, PEA. Certain nourishments, for example, nut oil, egg yolk, and soybean lecithin likewise contain PEA. On the off chance that the expression “endocannabinoid” sounds recognizable, it is on the grounds that “cannabis” is the term used to depict plants that produce delta-9-tetrahydrocannabinol (the primary dynamic fixing in the pot). You’ve most likely heard that weed (cannabis) can be utilized to treat glaucoma. There is proof that cannabinoids can be utilized to treat glaucoma. We certainly need all the more comprehension of Palmitoylethanolamide.

PEA is normally found in the entire body (the eye tissue that produces watery liquid). In patients with glaucoma, there is a diminished measure of PEA in the ciliary body.[5] It makes sense that on the off chance that patients with glaucoma have less PEA in their eyes, at that point maybe expanding the measure of PEA could treat glaucoma.

In fact, there are currently different examinations in which PEA has been appeared to bring down the intraocular pressure – IOP. Studies distributed in 2009 and 2012 looking at PEA against fake treatment showed a measurably noteworthy decrease in IOP with the utilization of PEA. A different report was introduced at a global gathering in 2013. Right now that got PEA had lower IOP and were more averse to lose vision.

PEA isn’t very cheap, but it is affordable. Be that as it may, on the off chance that you are keen on taking Palmitoylethanolamide (PEA) as a characteristic treatment for glaucoma, the industrially accessible structure, Pain Pro is $40-50 for a bundle of 90x400mg containers. As the investigation assessed patients who took an aggregate of 600mg every day the month to month cost of this treatment would be $45-60/month.